Drug name(s) | Preparation(s)¶ | Dose |
Albuterol MDIΔ | MDI: 90 mcg/inhalation (United States) MDI: 100 mcg/inhalation (Canada) |
|
Albuterol DPI | DPIΔ: 90 mcg/actuation (United States) |
|
Albuterol DPI (Canada) | DPI: 200 mcg/actuation (Canada) |
|
Albuterol solution for nebulization | Nebulizer solutions:
|
|
Albuterol-budesonide MDI | MDI: Albuterol 90 mcg and budesonide 80 mcg/actuation (United States) |
|
Levalbuterol MDIΔ | 45 mcg/inhalation (United States) |
|
Levalbuterol solution for nebulization | Nebulizer solution:
|
|
Terbutaline DPI | DPI: 0.5 mg/actuation (Canada) |
|
Ipratropium-albuterol SMI | SMI: Ipratropium 20 mcg and albuterol 100 mcg/inhalation (United States) |
|
Ipratropium-albuterol solution for nebulization | Nebulizer solution: Ipratropium 0.5 mg and albuterol 2.5 mg per 3 mL/vial‡ |
|
MDI: metered-dose inhaler; DPI: dry-powder inhaler; SMI: soft mist inhaler.
* Oral formulations of albuterol and terbutaline are less effective than inhaled formulations and are not recommended in asthma. Inhaled epinephrine (MDI or nebulized) is not recommended for routine use.
¶ Doses shown and strengths (ie, mcg per puff or inhalation) are based upon product descriptions approved in the United States and Canada as noted, which may differ from how strengths are described for products available in other countries. Consult local product information before use.
Δ Agent can also be used to prevent exercise-induced bronchoconstriction, 2 inhalations 5 to 20 minutes prior to exercise.
◊ Typically, two puffs are used for mild-to-moderate symptoms and four puffs for more severe symptoms; over the course of the first hour, the patient can determine (based on action plan or clinician guidance) whether to continue self-care at home or seek additional medical attention.
§ The number of inhalations is based on the severity of respiratory impairment, number of inhalations the patient has already used, and availability of monitoring. When administering an albuterol MDI for acute asthma exacerbation in an office or acute care setting, use of a valved holding chamber and careful attention to technique are recommended.
¥ Over the course of the first hour, the patient can determine (based on action plan or clinician guidance) whether to continue self-care at home or seek additional medical attention.
‡ Nebulizer solution in Canada is ipratropium 0.5 mg and albuterol 2.5 mg per 2.5 mL.Do you want to add Medilib to your home screen?